[Cultural influenza vaccines]

Area of Science:

• Virology
• Vaccinology
• Biotechnology

Background:

• Traditional influenza vaccines are produced using chicken embryos, which presents limitations.
• Cell-based vaccine production offers a potential alternative to conventional methods.
• Serum-free culture media are being explored to improve cell culture processes.

Purpose of the Study:

• To review recent advancements in influenza vaccine development utilizing cell cultures.
• To evaluate the safety and immunogenicity of cell-culture-derived influenza vaccines.
• To highlight the advantages of cell-culture vaccines over egg-based vaccines.

Main Methods:

• Utilized long-term cell cultures (MDSK or Vero) grown in bioreactors with microcarriers.
• Employed serum-free culture media for vaccine production.
• Conducted clinical trials to assess vaccine safety and immunogenicity.

Main Results:

• Inactivated cultural influenza vaccines demonstrated comparable safety and immunogenicity to conventional vaccines.
• Cell-culture vaccines showed advantages including standardized production and intact hemagglutinin antigen domains.
• Absence of protein allergens and potential contaminants from chicken embryos and serum was noted.

Conclusions:

• Cell-culture influenza vaccines produced in serum-free media are a viable and advantageous alternative.
• These vaccines offer enhanced safety profiles and simplified production scalability.
• Cultural influenza vaccines are poised for wider adoption in clinical practice.